We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
NXP Semiconductors
NXPI
$60.4B
| $29.8M | 0.05% |
261,527
+120,714
| +86% | +$12.1M |
|
|
TCF
152
DELISTED
TCF Financial Corporation Common Stock
TCF
| $29.7M | 0.05% |
1,008,215
+53,353
| +6% | +$1.47M |
|
153
Ciena
CIEN
$58.4B
| $29.6M | 0.05% |
546,187
+43,435
| +9% | +$2.16M |
|
|
AJRD
154
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $29.4M | 0.05% |
742,626
-7,369
| -1% | -$307K |
|
155
PJT Partners
PJT
$4.38B
| $29.4M | 0.05% |
+572,515
| New | +$28.2M |
|
156
Itron
ITRI
$4.54B
| $29.4M | 0.05% |
443,342
+38,291
| +9% | +$2.44M |
|
157
LCI Industries
LCII
$2.65B
| $29.3M | 0.05% |
254,448
+95,898
| +60% | +$8.83M |
|
158
Insulet
PODD
$9.79B
| $28.9M | 0.05% |
148,905
+11,721
| +9% | +$2.24M |
|
159
Arcosa
ACA
$7.11B
| $28.9M | 0.05% |
685,342
-15,898
| -2% | -$612K |
|
160
Littelfuse
LFUS
$11.6B
| $28.5M | 0.05% |
167,297
-6,504
| -4% | -$987K |
|
161
Kadant
KAI
$3.99B
| $28.3M | 0.05% |
283,745
-11,989
| -4% | -$1.07M |
|
162
Ares Management
ARES
$30.9B
| $28.3M | 0.05% |
711,852
+54,869
| +8% | +$1.94M |
|
163
Rambus
RMBS
$11B
| $27.7M | 0.04% |
1,824,769
+158,265
| +9% | +$2.23M |
|
164
ICF International
ICFI
$1.72B
| $27.5M | 0.04% |
424,697
-12,276
| -3% | -$805K |
|
|
HZNP
165
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $27.3M | 0.04% |
491,551
-912,729
| -65% | -$39M |
|
166
Monolithic Power Systems
MPWR
$68.9B
| $27.3M | 0.04% |
115,138
-253,761
| -69% | -$51.4M |
|
167
Huron Consulting
HURN
$2.42B
| $26.8M | 0.04% |
604,648
+8,274
| +1% | +$373K |
|
168
WEX
WEX
$6.31B
| $26.6M | 0.04% |
161,037
-9,932
| -6% | -$1.36M |
|
169
Guidewire Software
GWRE
$14.2B
| $26.5M | 0.04% |
239,252
+18,509
| +8% | +$1.78M |
|
|
ATSG
170
DELISTED
Air Transport Services Group
ATSG
| $26.5M | 0.04% |
1,187,921
+341,295
| +40% | +$7M |
|
171
HealthEquity
HQY
$8.75B
| $26.4M | 0.04% |
449,938
+142,022
| +46% | +$7.85M |
|
172
Americold
COLD
$4.27B
| $25.6M | 0.04% |
705,131
-41,099
| -6% | -$1.4M |
|
|
GWPH
173
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $25.6M | 0.04% |
208,560
+47,092
| +29% | +$5.34M |
|
|
CONE
174
DELISTED
CyrusOne Inc Common Stock
CONE
| $25.6M | 0.04% |
351,672
-9,217
| -3% | -$656K |
|
|
MYOK
175
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $25.5M | 0.04% |
263,912
-43,032
| -14% | -$3.59M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.